Cytokine regulation of skeletal muscle fatty acid metabolism: Effect of interleukin-6 and tumor necrosis factor-α

American Journal of Physiology - Endocrinology and Metabolism

Volumn 287, Issue 4 50-4, 2004, Pages

  Bruce, Clinton R ^a   Dyck, David J ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

Diacylglycerol; Fatty acid oxidation; Insulin resistance; Triacylglycerol

Indexed keywords

CYTOKINE; DIACYLGLYCEROL; FATTY ACID; INSULIN; INTERLEUKIN 6; LEPTIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ESTERIFICATION; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; FEMALE; INSULIN RESISTANCE; LIPOGENESIS; METABOLIC REGULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SOLEUS MUSCLE;

ANIMALS; CYTOKINES; DIGLYCERIDES; FATTY ACIDS; FEMALE; INSULIN RESISTANCE; INTERLEUKIN-6; KINETICS; LEPTIN; MUSCLE, SKELETAL; OXIDATION-REDUCTION; PALMITATES; RATS; RATS, SPRAGUE-DAWLEY; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 4544259980     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00150.2004     Document Type: Article

References (42)

1. Adams JM II, Pratipanawatr T, Berria R, Wang E, DeFronzo RA, Sullards MC, and Mandarine LJ. Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Diabetes 53: 25-31, 2004.
2. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, and Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin. in obesity. Biochem Biophys Res Commun 257; 79-83, 1999.
3. Bastard JP, Maachi M, Van Nhieu JT, Jardel C, Bruckert E, Grimaldi A, Robert JJ, Capeau J, and Hainque B. Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab 87: 2084-2089, 2002.
4. Combs TP, Wagner JA, Berger J, Doebber T, Wang WJ, Zhang BB, Tanen M, Berg AH, O'Rahilly S, Savage DB, Chatterjee K, Weiss S, Larson PJ, Gottesdiener KM, Gertz BJ, Charron MJ, Scherer PE, and Moller DE. Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization. Endocrinology 143: 998-1007, 2002.
5. Cooney GJ, Thompson AL, Furler SM, Ye J, and Kraegen EW. Muscle long-chain acyl CoA esters and insulin resistance. Ann NY Acad Sci 967: 196-207, 2002.
6. De Alvaro C, Teruel T, Hernandez R, and Lorenzo M. Tumor necrosis factor-alpha produces insulin resistance in skeletal muscle by activation of inhibitor κB kinase in a p38 mitogen-activated protein kinase-dependent manner. J Biol Chem 279: 17070-17078, 1994.
7. Dyck DJ, Peters SJ, Glatz J, Gorski J, Keizer H, Kiens B, Liu S, Richter EA, Spriet LL, Van Der Vusse GJ, and Bonen A. Functional differences in lipid metabolism in resting skeletal muscle of various fibre types. Am J Physiol Endocrinol Metab 272: E340-E351, 1997.
8. Goodpaster BH, Katsiaras A, and Kelley DE. Enhanced fat oxidation through physical activity is associated with improvements in insulin sensitivity in obesity. Diabetes 52: 2191-2197, 2003.
9. Green A, Rumberger JM, Stuart CA, and Ruhoff MS. Stimulation of lipolysis by tumor necrosis factor-α in 3T3-L1 adipocytes is glucose dependent. Implications for long-term regulation of lipolysis. Diabetes 53: 74-81, 2004.
10. Hirosumi J, Tuneman G, Chang L, Görgün CZ, Uysal KT, Maeda K, Karin M, and Hotamisligil GS. A central role for JNK in obesity and insulin resistance. Nature 420: 333-336, 2002.
11. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, and Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest 95: 2409-2415, 1995.
12. Hotamisligil GS, Budavari A, Murray D, and Spiegelman BM. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-α. J Clin Invest 94: 1543-1549, 1994.
13. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, and Spiegelman BM. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α- and obesity-induced insulin resistance. Science 271: 665-668, 1996.
14. Itani SI, Ruderman NB, Schmieder F, and Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and 1κB-α. Diabetes 51: 2005-2011, 2002.
15. Kamohara S, Burcelin R, Halaas JL, Friedman JM, and Charron MJ. Acute stimulation of glucose metabolism in mice by leptin treatment. Nature 389: 374-7, 1997.
16. Kelley DE, Goodpaster B, Wing RR, and Simoneau JA. Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am J Physiol Endocrinol Metab 277: E1130-E1141, 1999.
17. Kolesnick RN. 1,2-Diacylglycerols but not phorbol esters stimulate sphingomyelin hydrolysis in GH3 pituitary cells. J Biol Chem 262: 16759-16762, 1987.
18. Lang CH, Dobrescu C, and Bagby GJ. Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology 130: 43-52, 1992.
19. MacDonald C, Wojtaszewski JF, Pedersen BK, Kiens B, and Richter EA. Interleukin-6 release from human skeletal muscle during exercise: relation to AMPK activity. J Appl Physiol 95: 2273-2277, 2003.
20. Merrill GF, Kurth EJ, Hardie DG, and Winder WW. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am J Physiol Endocrinol Metab 273: E1107-E1112, 1997.
21. Minokoshi Y, Kim YB, Peroni OD, Fryer LGD, Müller C, Carling D, and Kahn BB. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415: 339-343, 2002.
22. Muoio DM, Dohm GL, Fiedorek FT Jr, Tapscott EB, and Coleman RA. Leptin directly alters lipid partitioning in skeletal muscle. Diabetes 46: 1360-1363, 1997.
23. Pan DA, Lillioja S, Kriketos AD, Milner MR, Baur LA, Bogardus C, Jenkins AB, and Storlien LH. Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 46: 983-988, 1997.
24. Reaven GM, Hollenbeck C, Jeng CY, Wu MS, and Chen YD. Measurement of plasma glucose, free fatty acid, lactate and insulin for 24 h in patients with NIDDM. Diabetes 37: 1020-1024, 1988.
25. Saghizadeh M, Ong JM, Garvey WT, Henry RR, and Kern PA. The expression of TNF alpha by human muscle. Relationship to insulin resistance. J Clin Invest 97: 1111-1116, 1996.
26. Sethi JK and Hotamisligil GS. The role of TNFα in adipocyte metabolism. Semin Cell Dev Biol 10: 19-29, 1999.
27. Schmitz-Peiffer C, Browne CL, Oakes ND, Watkinson A, Chisholm DJ, Kraegen EW, and Biden TJ. Alterations in the expression and cellular localization of protein kinase C isoforms ε and θ are associated with insulin resistance in skeletal muscle of the high-fat-fed rat. Diabetes 46: 169-178, 1997.
28. Schmitz-Peiffer C, Craig DL, and Biden TJ. Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate. J Biol Chem 274: 24202-24210, 1999.
29. Schutze S, Berkovic D, Tomsing O, Unger C, and Kronke M. Tumor necrosis factor induces rapid production of 1′2′ diacylglycerol by a phosphatidylcholine-specific phospholipiase C. J Exp Med 174: 975-988, 1991.
30. Steensberg A, Fischer CP, Sacchetti M, Keller C, Osada T, Schjerling P, van Hall G, Febbraio M, and Pedersen BK. Acute interleukin-6 administration does not impair muscle glucose uptake or whole-body glucose disposal in healthy humans. J Physiol 548: 631-638, 2003.
31. Steensberg A, Keller C, Starkie RL, Osada T, Febbraio MA, and Pedersen BK. IL-6 and TNF-alpha expression in, and release from, contracting human skeletal muscle. Am J Physiol Endocrinol Metab 283: E1272-E1278, 2002.
32. Steinberg GR, Bonen A, and Dyck DJ. Fatty acid oxidation and triacylglycerol hydrolysis are enhanced after chronic leptin treatment in rats. Am J Physiol Endocrinol Metab 282: E593-E600, 2002.
33. Steinberg GR and Dyck DJ. Development of leptin resistance in rat soleus muscle in response to high-fat diets. Am J Physiol Endocrinol Metab 279: E1374-E1382, 2000.
34. Steinberg GR, Parolin ML, Heigenhauser GJF, and Dyck DJ. Leptin increases FA oxidation in lean but not obese human skeletal muscle: evidence of peripheral leptin resistance. Am J Physiol Endocrinol Metab 283: E187-E192, 2002.
35. Summers SA, Garza AL, Zhou H, and Birnbaum MJ. Regulation of insulin-stimulated glucose transporter GLUT4 translocation and Akt kinase activity by ceramide. Mol Cell Biol 18: 5457-5464, 1998.
36. Van Hall G, Steensberg A, Sacchetti M, Fischer C, Keller C, Schjerling P, Hiscock N, Møller K, Saltin B, Febbraio MA, and Pedersen BK. Interleukin-6 stimulates lipolysis and fat oxidation in humans. J Clin Endocrinol Metab 88: 3005-3010, 2003.
37. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, and Kadowaki T. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8: 1288-1295, 2002.
38. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, and Kadowaki T. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7: 941-946, 2001.
39. Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, Bergeron R, Kim JK, Cushman SW, Cooney GJ, Atcheson B, White MF, Kraegen EW, and Shulman GI. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 277: 50230-50236, 2002.
40. Zhang Y, Pilon G, Marette A, and Baracos VE. Cytokines and endotoxin induce cytokine receptors in skeletal muscle. Am J Physiol Endocrinol Metab 279: E196-E205, 2000.
41. Zinman B, Hanley AJ, Harris SB, Kwan J, and Fantus IG. Circulating tumor necrosis factor-alpha concentrations in a native Canadian population with high rates of type 2 diabetes mellitus. J Clin Endocrinol Metab 84: 272-278. 1999.
42. Zurlo F, Larson K, Bogardus C, and Ravussin E. Skeletal muscle metabolism is a major determinant of resting energy expenditure. J Clin Invest 86: 1423-1427, 1990.